glp-1 bacteria Discovery of a bacterial peptide as a modulator of and metabolic disease GLP-1 is produced by specialized

Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer

Specifically, the review focuses on: the classification and key characteristics of the most commonly used anabolicandrogenic agents, their pharmacological effects and the most frequently reported adverse reactions, psychological determinants and consequences of anabolicandrogenic substance use, including muscle dysmorphia and social pressure, clinical management strategies, including approaches to restoring hypothalamicpituitarytesticular (HPT) axis function in individuals abusing testosterone

Some early reports suggest that reducing dose frequency may help certain patients maintain weight loss, but experts also caution that microdosing itself is loosely defined and not supported by robust long-term data

2026 Jun 21;15(12):1120